Treatment of Type 2 Diabetes in Childhood Using a Very-Low-Calorie Diet von WILLI, Steven M, MARTIN, Kelley, DATKO, Farrah M, BRANT, Bethany P

Volltext

Abstract OT3-09-01: Clinical Trial of Alpelisib and Tucatinib in Patients with PIK3CA-Mutant HER2-Positive Metastatic Breast Cancer von Shagisultanova, Elena, Wisinski, Kari B., Gawryletz, Chelsea D., Datko, Farrah M., Medgyesy, Diana, Diamond, Jennifer R., Borges, Virginia F., Kabos, Peter

Volltext

Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC) von Shah, Payal D, Moynahan, Mary Ellen, Modi, Shanu, Caravella, Betty Ann, Datko, Farrah M, Zamora, Stephen, Comen, Elizabeth, Gilewski, Theresa, Sugarman, Steven M, D'Andrea, Gabriella, Lake, Diana E, Goldfarb, Shari B, Patil, Sujata, Covey, Anne, Berger, Michael F, Lacouture, Mario E, Norton, Larry, Hudis, Clifford A, Baselga, Jose, Chandarlapaty, Sarat, Dickler, Maura N

Volltext

Phase I trial of daily PI3Kα inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC) von Shah, Payal Deepak, Modi, Shanu, Datko, Farrah Mikhail, Moynahan, Mary Ellen, Zamora, Stephen, D'Andrea, Gabriella, Lake, Diana, Goldfarb, Shari Beth, Patil, Sujata, Singh, Sharat, Langley, Emma J., Kim, Phillip Sangwook, Covey, Anne M., Caravella, Betty Ann, Berger, Michael F., Lacouture, Mario E., Hudis, Clifford A., Baselga, Jose, Chandarlapaty, Sarat, Dickler, Maura N.

Volltext